The Trump administration announced plans to crack down on pharmaceutical advertising on television and social media platforms that could disrupt billions of dollars in annual ad spending.
President Donald Trump signed a presidential memorandum on Tuesday that calls on federal health agencies to require pharmaceutical companies to disclose more side effects in their ads and enforce existing rules about misleading ads. The administration is pitching the moves as a way to increase transparency for patients.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.